SARS-CoV-2 productively infects human gut enterocytes

Mart M. Lamers, Joep Beumer(Royal Netherlands Academy of Arts and Sciences), Jelte van der Vaart(Royal Netherlands Academy of Arts and Sciences), Kèvin Knoops(Maastricht University), Jens Puschhof(Royal Netherlands Academy of Arts and Sciences), Tim I. Breugem, Raimond B. G. Ravelli(Maastricht University), J. Paul van Schayck(Maastricht University), Anna Z. Mykytyn, Hans Q. Duimel(Maastricht University), Elly van Donselaar(Maastricht University), Samra Riesebosch, Helma J.H. Kuijpers(Maastricht University), Debby Schipper, Willine J. van de Wetering(Maastricht University), Miranda de Graaf, Marion Koopmans, Edwin Cuppen(Oncode Institute), Peter J. Peters(Maastricht University), Bart L. Haagmans, Hans Clevers(Royal Netherlands Academy of Arts and Sciences)
Science
May 1, 2020
Cited by 1,665Open Access
Full Text

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause coronavirus disease 2019 (COVID-19), an influenza-like disease that is primarily thought to infect the lungs with transmission through the respiratory route. However, clinical evidence suggests that the intestine may present another viral target organ. Indeed, the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) is highly expressed on differentiated enterocytes. In human small intestinal organoids (hSIOs), enterocytes were readily infected by SARS-CoV and SARS-CoV-2, as demonstrated by confocal and electron microscopy. Enterocytes produced infectious viral particles, whereas messenger RNA expression analysis of hSIOs revealed induction of a generic viral response program. Therefore, the intestinal epithelium supports SARS-CoV-2 replication, and hSIOs serve as an experimental model for coronavirus infection and biology.


Related Papers

No related papers found

Powered by citation graph analysis